BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33492451)

  • 1. Cyclophilin A: a key player for etiological agent infection.
    Liao Y; Luo D; Peng K; Zeng Y
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1365-1377. PubMed ID: 33492451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy.
    Dawar FU; Tu J; Khattak MN; Mei J; Lin L
    Curr Issues Mol Biol; 2017; 21():1-20. PubMed ID: 27033630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human MxB Inhibits the Replication of Hepatitis C Virus.
    Yi DR; An N; Liu ZL; Xu FW; Raniga K; Li QJ; Zhou R; Wang J; Zhang YX; Zhou JM; Zhang LL; An J; Qin CF; Guo F; Li XY; Liang C; Cen S
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophilin inhibitors as antiviral agents.
    Peel M; Scribner A
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4485-92. PubMed ID: 23849880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin A is the potential receptor of the Mycoplasma genitalium adhesion protein.
    Deng X; Dai P; Yu M; Chen L; Zhu C; You X; Li L; Zeng Y
    Int J Med Microbiol; 2018 Apr; 308(3):405-412. PubMed ID: 29551599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma genitalium Protein of Adhesion Suppresses T Cell Activation via CypA-CaN-NFAT Pathway.
    Luo D; Luo H; Yan X; Lei A; He J; Liao Y; Peng K; Li X; Ye Y; Chen L; Zeng Z; Xiao H; Zeng Y
    Microbiol Spectr; 2023 Jun; 11(3):e0450322. PubMed ID: 37074201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin A and viral infections.
    Zhou D; Mei Q; Li J; He H
    Biochem Biophys Res Commun; 2012 Aug; 424(4):647-50. PubMed ID: 22814107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways.
    Liu X; Zhao Z; Li Z; Xu C; Sun L; Chen J; Liu W
    PLoS One; 2012; 7(5):e37277. PubMed ID: 22615963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.
    Hopkins S; Bobardt M; Chatterji U; Garcia-Rivera JA; Lim P; Gallay PA
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3888-97. PubMed ID: 22585215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophilin A: a possible host modulator in Chandipura virus infection.
    Pavitrakar DV; Atre NM; Tripathy AS; Shil P
    Arch Virol; 2021 Nov; 166(11):3143-3150. PubMed ID: 34533641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production.
    Phillips S; Chokshi S; Chatterji U; Riva A; Bobardt M; Williams R; Gallay P; Naoumov NV
    Gastroenterology; 2015 Feb; 148(2):403-14.e7. PubMed ID: 25305505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.
    Kaul A; Stauffer S; Berger C; Pertel T; Schmitt J; Kallis S; Zayas M; Lohmann V; Luban J; Bartenschlager R
    PLoS Pathog; 2009 Aug; 5(8):e1000546. PubMed ID: 19680534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Roles of Cyclophilin A in Regulating Viral Cloaking.
    Mamatis JE; Pellizzari-Delano IE; Gallardo-Flores CE; Colpitts CC
    Front Microbiol; 2022; 13():828078. PubMed ID: 35242122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
    Ma-Lauer Y; Zheng Y; Malešević M; von Brunn B; Fischer G; von Brunn A
    Antiviral Res; 2020 Jan; 173():104620. PubMed ID: 31634494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cyclophilin A on the replication of red spotted grouper nervous necrosis virus associates with multiple pro-inflammatory factors.
    Asim M; Sarath Babu V; Qin Z; Zhao L; Su J; Li J; Tu J; Kou H; Lin L
    Fish Shellfish Immunol; 2019 Sep; 92():172-180. PubMed ID: 31176008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the roles of cyclophilin A during influenza virus infection.
    Liu X; Zhao Z; Liu W
    Viruses; 2013 Jan; 5(1):182-91. PubMed ID: 23322171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein.
    Liu X; Zhao Z; Xu C; Sun L; Chen J; Zhang L; Liu W
    PLoS One; 2012; 7(2):e31063. PubMed ID: 22347431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophilin A: a key player for human disease.
    Nigro P; Pompilio G; Capogrossi MC
    Cell Death Dis; 2013 Oct; 4(10):e888. PubMed ID: 24176846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein.
    Qing M; Yang F; Zhang B; Zou G; Robida JM; Yuan Z; Tang H; Shi PY
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3226-35. PubMed ID: 19451286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
    Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
    J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.